Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy

The invention relates to a gene transfer vector, comprising at least one nucleic acid molecule comprising a first nucleic acid sequence which codes for one or more ligands that trigger apoptosis, a second nucleic acid sequence which codes for one or more antigens, optionally, a third nucleic acid se...

Full description

Saved in:
Bibliographic Details
Main Author FRITZ SCHWARZMANN
Format Patent
LanguageEnglish
Published 14.07.2005
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a gene transfer vector, comprising at least one nucleic acid molecule comprising a first nucleic acid sequence which codes for one or more ligands that trigger apoptosis, a second nucleic acid sequence which codes for one or more antigens, optionally, a third nucleic acid sequence which codes for one or more anti-apoptosis molecules, and optionally, a fourth nucleic acid sequence which codes for one or more suicide enzymes.
Bibliography:Application Number: AU2147901